GENERINI, SERGIO
GENERINI, SERGIO
MEDICINA INTERNA (attivo dal 01/01/1999 al 31/12/2012)
[Peripheral nervous system in limited systemic sclerosis].
2004 Del Rosso A;Ibba-Manneschi L;Tani A;Nosi D;Franca Milia A;Generini S;Guiducci S;Melchiorre D;Pignone A;Matucci Cerinic M
A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects
2010 D. Melchiorre; Generini, S.; Bandinelli, F.; Porta, F.; Maddali-Bongi, S.; Matucci-Cerinic, M.
Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis.
2002 KALFIN R; RIGHI A; DEL ROSSO A; BAGCHI D; GENERINI S; GUIDUCCI S; MATUCCI CERINIC M; DAS D K
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis
2007 Bartoli F.; Angotti C.; Fatini C.; Conforti M.L.; Guiducci S.; Blagojevic J.; Melchiorre D.; Fiori G.; Generini S.; Damjanov N.; Rednic S.; Pignone A.; Castellani S.; Abbate R.; Cerinic M.M.
Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades.
2012 Salvadorini G;Bandinelli F;Delle Sedie A;Riente L;Candelieri A;Generini S;Possemato N;Bombardieri S;Matucci Cerinic M
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
1998 Pignone A;Scaletti C;Matucci Cerinic M;Vázquez-Abad D;Meroni PL;Del Papa N;Falcini F;Generini S;Rothfield N;Cagnoni M
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?
1999 Falcini F;Generini S;Pignone A;Leoncini G;Cimaz R;Partsch G;Matucci Cerinic M
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis.
2000 Falcini F; Calzolari A; Generini S; Pignone A; Simonini G; Zulian F; Matucci Cerinic M.
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis.
2007 KALOUDI O; BASTA G; PERFETTO F; BARTOLI F; DEL ROSSO A; MINIATI I; CONFORTI ML; GENERINI S; GUIDUCCI S; ABBATE R; PIGNONE A; CASTELLANI S; LIVI R; DE CATERINA R; MATUCCI CERINIC M
Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review.
1997 Generini S;Ermini M;Taccetti G;Trapani S;Cerinic MM;Falcini F
Current Treatment Options in Raynaud's Phenomenon.
2003 Generini S;Del Rosso A;Pignone A;Matucci Cerinic M
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
2002 Giacomelli R;Valentini G;Salsano F;Cipriani P;Sambo P;Conforti ML;Fulminis A;De Luca A;Farina G;Candela M;Generini S;De Francisci A;Tirri E;Proietti M;Bombardieri S;Gabrielli A;Tonietti G;Cerinic MM
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis
2005 L. IBBA-MANNESCHI; A. DEL ROSSO; A.F. MILIA; A. TANI; D. NOSI; A. PIGNONE; S. GENERINI; R. GIACOMELLI; M. MATUCCI CERINIC
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis.
2000 Simonini G; Falcini F; Generini S; Pignone A; Matucci Cerinic M.
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis.
1999 MATUCCI CERINIC M; IANNONE F; CAROSSINO A.M.; MOGGI PIGNONE A; LEONCINI G; GENERINI S; LAPADULA G; CAGNONI M.
DRESS syndrome in a patient with chronic hepatic encephalopathy.
2016 Roberto Giulio Romanelli; Tommaso Gabbani; Maria Marsico; Fabrizia Natucci; Veronica Almerigogna; Elisa Triboli; Sergio Generini; Cristina Stasi; Giacomo Laffi
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis
2002 P. FAILLI; PALMIERI L.; D’ALFONSO C.; GIOVANNELLI L.; GENERINI S.; DEL ROSSO A.; PIGNONE A.; STANFLIN N.; ORSI S.; ZILLETTI L.; MATUCCI-CERINIC M.
Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677))
2005 F Bandinelli , F Bartoli, E Perfetto, A Del Rosso, A Moggi-Pignone, S Guiducci, M Cinelli, C Fatini, S Generini, A Gabrielli, R Giacomelli, S Maddali Bongi, R Abbate, M Del Rosso, M Matucci Cerinic
Estrogens and neuropeptides in Raynaud's phenomenon.
2005 GENERINI S; SEIBOLD JR; MATUCCI CERINIC M
Evidence for hyaluronan production in the air pouch model in rats.
2001 Generini S;Matucci Cerinic M;Partsch G;Stancikova M;Pignone A;Konttinen YT;Rovensky J;Baker DJ;Schumacher HR Jr
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Peripheral nervous system in limited systemic sclerosis]. | 2004 | Del Rosso A;Ibba-Manneschi L;Tani A;Nosi D;Franca Milia A;Generini S;Guiducci S;Melchiorre D;Pignone A;Matucci Cerinic M | |
| A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects | 2010 | D. Melchiorre; Generini, S.; Bandinelli, F.; Porta, F.; Maddali-Bongi, S.; Matucci-Cerinic, M. | |
| Activin, a grape seed derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. | 2002 | KALFIN R; RIGHI A; DEL ROSSO A; BAGCHI D; GENERINI S; GUIDUCCI S; MATUCCI CERINIC M; DAS D K | |
| Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis | 2007 | Bartoli F.; Angotti C.; Fatini C.; Conforti M.L.; Guiducci S.; Blagojevic J.; Melchiorre D.; Fiori G.; Generini S.; Damjanov N.; Rednic S.; Pignone A.; Castellani S.; Abbate R.; Cerinic M.M. | |
| Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. | 2012 | Salvadorini G;Bandinelli F;Delle Sedie A;Riente L;Candelieri A;Generini S;Possemato N;Bombardieri S;Matucci Cerinic M | |
| Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. | 1998 | Pignone A;Scaletti C;Matucci Cerinic M;Vázquez-Abad D;Meroni PL;Del Papa N;Falcini F;Generini S;Rothfield N;Cagnoni M | |
| Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? | 1999 | Falcini F;Generini S;Pignone A;Leoncini G;Cimaz R;Partsch G;Matucci Cerinic M | |
| Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. | 2000 | Falcini F; Calzolari A; Generini S; Pignone A; Simonini G; Zulian F; Matucci Cerinic M. | |
| Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. | 2007 | KALOUDI O; BASTA G; PERFETTO F; BARTOLI F; DEL ROSSO A; MINIATI I; CONFORTI ML; GENERINI S; GUIDUCCI S; ABBATE R; PIGNONE A; CASTELLANI S; LIVI R; DE CATERINA R; MATUCCI CERINIC M | |
| Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review. | 1997 | Generini S;Ermini M;Taccetti G;Trapani S;Cerinic MM;Falcini F | |
| Current Treatment Options in Raynaud's Phenomenon. | 2003 | Generini S;Del Rosso A;Pignone A;Matucci Cerinic M | |
| Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. | 2002 | Giacomelli R;Valentini G;Salsano F;Cipriani P;Sambo P;Conforti ML;Fulminis A;De Luca A;Farina G;Candela M;Generini S;De Francisci A;Tirri E;Proietti M;Bombardieri S;Gabrielli A;Tonietti G;Cerinic MM | |
| Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis | 2005 | L. IBBA-MANNESCHI; A. DEL ROSSO; A.F. MILIA; A. TANI; D. NOSI; A. PIGNONE; S. GENERINI; R. GIACOMELLI; M. MATUCCI CERINIC | |
| Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. | 2000 | Simonini G; Falcini F; Generini S; Pignone A; Matucci Cerinic M. | |
| Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. | 1999 | MATUCCI CERINIC M; IANNONE F; CAROSSINO A.M.; MOGGI PIGNONE A; LEONCINI G; GENERINI S; LAPADULA G; CAGNONI M. | |
| DRESS syndrome in a patient with chronic hepatic encephalopathy. | 2016 | Roberto Giulio Romanelli; Tommaso Gabbani; Maria Marsico; Fabrizia Natucci; Veronica Almerigogna; Elisa Triboli; Sergio Generini; Cristina Stasi; Giacomo Laffi | |
| Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis | 2002 | P. FAILLI; PALMIERI L.; D’ALFONSO C.; GIOVANNELLI L.; GENERINI S.; DEL ROSSO A.; PIGNONE A.; STANFLIN N.; ORSI S.; ZILLETTI L.; MATUCCI-CERINIC M. | |
| Erratum: "The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn) (Clinical and Experimental Rheumatol (2005) vol. 23 (5) (671-677)) | 2005 | F Bandinelli , F Bartoli, E Perfetto, A Del Rosso, A Moggi-Pignone, S Guiducci, M Cinelli, C Fatini, S Generini, A Gabrielli, R Giacomelli, S Maddali Bongi, R Abbate, M Del Rosso, M Matucci Cerinic | |
| Estrogens and neuropeptides in Raynaud's phenomenon. | 2005 | GENERINI S; SEIBOLD JR; MATUCCI CERINIC M | |
| Evidence for hyaluronan production in the air pouch model in rats. | 2001 | Generini S;Matucci Cerinic M;Partsch G;Stancikova M;Pignone A;Konttinen YT;Rovensky J;Baker DJ;Schumacher HR Jr |